Sandoz to market generic Skelaxin
PRINCETON, N.J. Sandoz has launched a generic version of a muscle relaxant, the generics arm of Swiss drug maker Novartis said Thursday.
Sandoz announced the launch of metaxalone tablets, used to treat such acute skeletal muscle conditions as lower back spasms resulting from injury.
The drug is a generic version of King Pharmaceuticals’ Skelaxin, which had sales of around $476 million in 2009, according to IMS Health. Sandoz was the first company to file for regulatory approval of a generic version of the drug, entitling it to six months in which to compete directly with the branded version, under the provisions of the Hatch-Waxman Act of 1984.